Halozyme Therapeutics, Inc. earnings per share and revenue

HALO earnings per share for the last quarter are 1.27 USD whereas the estimation was 0.96 USD which accounts for 32.57% surprise. Company revenue for the same period amounts to 290.08 M USD despite the estimated figure of 252.17 M USD. Estimated earnings per share for the next quarter are 1.17 USD, and revenue is expected to reach 293.61 M USD. Also watch annual changes over time to get a bigger picture of HALO earnings per share and revenue dynamics.